Erwin J. Hoogervorst

St. Antonius Hospital
Utrecht, UT, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

Treatment satisfaction during personalized extended interval dosing of natalizumab in patients with multiple sclerosis.

Treatment satisfaction during personalized extended interval dosing of natalizumab in patients with multiple sclerosis.

Journal: Multiple sclerosis and related disorders

Published: April 30, 2026

Individual Variability of CD19+ B-Cell Repopulation in People With Multiple Sclerosis Treated With Extended Interval Dosing of Ocrelizumab.

Individual Variability of CD19+ B-Cell Repopulation in People With Multiple Sclerosis Treated With Extended Interval Dosing of Ocrelizumab.

Journal: European journal of neurology

Published: March 19, 2026

Prevalence and presenting symptoms of intracranial hemorrhage in older adults presenting with subacute head injuries in a level-2 trauma center: A retrospective cohort study.

Prevalence and presenting symptoms of intracranial hemorrhage in older adults presenting with subacute head injuries in a level-2 trauma center: A retrospective cohort study.

Journal: Injury

Published: December 07, 2025

Cranial CT scans rarely result in neurosurgical transfers in older adults over 80 years with acute head injuries: A retrospective cohort study.

Cranial CT scans rarely result in neurosurgical transfers in older adults over 80 years with acute head injuries: A retrospective cohort study.

Journal: Injury

Published: November 20, 2025

Reliability of serum neurofilament light and glial fibrillary acidic protein for detecting disease activity upon discontinuation of first-line disease-modifying therapy in stable multiple sclerosis (DOT-MS).

Reliability of serum neurofilament light and glial fibrillary acidic protein for detecting disease activity upon discontinuation of first-line disease-modifying therapy in stable multiple sclerosis (DOT-MS).

Journal: Journal of neurology

Published: June 16, 2025

Spheres of uncertainty: A phenomenological inquiry into healthcare practice surrounding the care for people with relapsing-remitting multiple sclerosis.

Spheres of uncertainty: A phenomenological inquiry into healthcare practice surrounding the care for people with relapsing-remitting multiple sclerosis.

Journal: Qualitative research in medicine & healthcare

Published: February 14, 2025

Low natalizumab trough concentrations are associated with reduced seroconversion of the John Cunningham virus in natalizumab-treated patients with multiple sclerosis.

Low natalizumab trough concentrations are associated with reduced seroconversion of the John Cunningham virus in natalizumab-treated patients with multiple sclerosis.

Journal: Journal of neurology, neurosurgery, and psychiatry

Published: December 31, 2024

Discontinuation of First-Line Disease-Modifying Therapy in Patients With Stable Multiple Sclerosis: The DOT-MS Randomized Clinical Trial.

Discontinuation of First-Line Disease-Modifying Therapy in Patients With Stable Multiple Sclerosis: The DOT-MS Randomized Clinical Trial.

Journal: JAMA neurology

Published: December 09, 2024

Influence of personalized extended interval dosing on the natalizumab wearing-off effect - a sub-study of the NEXT-MS trial.

Influence of personalized extended interval dosing on the natalizumab wearing-off effect - a sub-study of the NEXT-MS trial.

Journal: Journal of the neurological sciences

Published: March 15, 2024

Whole Exome Sequencing in Multi-Incident Families Identifies Novel Candidate Genes for Multiple Sclerosis.

Whole Exome Sequencing in Multi-Incident Families Identifies Novel Candidate Genes for Multiple Sclerosis.

Journal: International journal of molecular sciences

Published: August 24, 2022

Patient decision aid based on multi-criteria decision analysis for disease-modifying drugs for multiple sclerosis: prototype development.

Patient decision aid based on multi-criteria decision analysis for disease-modifying drugs for multiple sclerosis: prototype development.

Journal: BMC medical informatics and decision making

Published: January 14, 2021

Varicella zoster-associated acute retinal necrosis and central nervous system complications in natalizumab treated MS patients.

Varicella zoster-associated acute retinal necrosis and central nervous system complications in natalizumab treated MS patients.

Journal: Multiple sclerosis and related disorders

Published: October 30, 2020

Showing 1-12 of 22

Last Updated: 09/26/2026